SAN DIEGO and TORONTO Jan GLOBE NEWSWIRE -- Aptose Biosciences Inc Aptose or the Company Nasdaq APTO TSX APS a clinical-stage precision oncology company developing highly differentiated targeted agents to treat hematologic malignancies today announced the closing of the previously announced public offering the Public Offering of common shares of the Company the Common Shares and warrants at a combined...
Globe News Wire
COPENHAGEN Denmark Jan GLOBE NEWSWIRE -- Ascendis Pharma A S Nasdaq ASND today announced that YORVIPATH palopegteriparatide developed as TransCon PTH a parathyroid hormone PTH replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism is now available in Germany and Austria YORVIPATH is the second product developed with Ascendis Pharma s TransCon technology platform to be launched commercially...
WALTHAM Mass Jan GLOBE NEWSWIRE -- Xilio Therapeutics Inc Nasdaq XLO a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer today announced that Ren Russo Pharm D president and chief executive officer will participate in a fireside chat at the Guggenheim th Annual Biotechnology Conference on Wednesday February at pm EST A live webcast...
CALGARY Alberta Jan GLOBE NEWSWIRE -- PrairieSky will release its annual and fourth quarter results on Monday February after markets close The news release detailing PrairieSky s fourth quarter and year-end results will provide operating and financial information Financial statements management s discussion and analysis and the annual information form will be available on PrairieSky s website at www prairiesky...